Navigation Links
Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
Date:4/9/2012

Combining two strategies designed to improve the results of cancer treatment antiangiogenesis drugs and nanomedicines may only be successful if the smallest nanomedicines are used. A new study from Massachusetts General Hospital (MGH) researchers, appearing in Nature Nanotechnology, finds that normalizing blood vessels within tumors, which improves the delivery of standard chemotherapy drugs, can block the delivery of larger nanotherapy molecules.

"We found that vascular normalization only increases the delivery of the smallest nanomedicines to cancer cells," says Vikash P. Chauhan, of the Steele Laboratory of Tumor Biology in the MGH Radiation Oncology Department, lead author of the report. "We also showed that the smallest nanomedicines are inherently better than larger nanomedicines at penetrating tumors, suggesting that smaller nanomedicines may be ideal for cancer therapy."

Tumors need to generate their own blood supply to continue growing, but vessels supplying tumors tend to be disorganized, oversized and leaky. Not only does this prevent the delivery of chemotherapy drugs to cells not close to tumor vessels, but the leakage of plasma out of blood vessels increases pressure within the tumor, further reducing the ability of drugs to penetrate tumors. Treatment with drugs that inhibit angiogenesis the process by which new vessels are generated reduces some of these abnormalities, a process called vascular normalization that has been shown to improve treatment of some cancers with standard chemotherapy drugs.

Nanomedicines are actually designed to exploit tumor vessel abnormality. While the molecules of standard chemotherapy drugs are about one nanometer a billionth of a meter nanomedicine molecules are from 10 to 100 times larger, too large to penetrate the pores of blood vessels in normal tissues but small enough to pass through the oversized pores of tumor vessels. Since the size of nanomedicines should k
'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Novel Method Eyed for Normalizing Blood Sugar
2. Improved Stem Cell Line May Avoid Tumor Risk: Study
3. Oxygen in tumors predicts prostate cancer recurrence
4. 2 targeted therapies act against Ewings sarcoma tumors
5. Freezing Secondary Breast Cancer Tumors Shows Promise
6. Cancer treatment system sculpts radiation beam to match shape of a tumor
7. How cancer cells start new tumor sites
8. Rare medical phenomenon of systemic tumor disappearance following local radiation treatment reported in a patient with metastatic melanoma
9. Study shows advance in using patients own tumor-fighting cells to knock back advanced melanoma
10. A culprit behind brain tumor resistance to therapy
11. Vitamin D shrinks fibroid tumors in rats
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 30, 2014 Seniors Guide, the comprehensive guide ... focus on Alzheimer’s Disease, Dementia, and Memory Loss . ... public of being diagnosed with the Alzheimer’s, inspired Seniors Guide ... Be Me”. The movie, out on October 14, 2014, ... his diagnosis of the disease – which inspires a final ...
(Date:8/30/2014)... 2014 Continuing to meet the skin ... with the addition of a new doctor and office ... provided leading-edge skin care in Grand Rapids since 1980 ... “As a doctor, my passion is making sure my ... Forefront Dermatology, I’m better able to focus on my ...
(Date:8/30/2014)... Hastings and Hastings, a qualified team of ... is pleased to report having saved a client $67,100 ... many cases where Hastings and Hastings has tailored its ... greater portion of their settlement or recovery. The firm ... solution for Arizona car accident victims is achievable through ...
(Date:8/30/2014)... 30, 2014 Market Research Report ... is a professional and in-depth market survey on ... firstly reviews the basic information of Lab Oven ... report then explores global and China’s top manufacturers ... production value, and market share etc. , The ...
(Date:8/30/2014)... Bringing forth the great opportunities, ... the Labor Day discount on all SEO services. While ... complete services related to internet marketing. Their dedicated team ... others do have a deep understanding for their specialization. ... work and since the inception, they have worked with ...
Breaking Medicine News(10 mins):Health News:Alzheimer’s Disease and Dementia Focus on Retirement Website SeniorsGuideOnline.com 2Health News:Expanding Care at the Forefront of Dermatology 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Profit By Search Announces Labor Day Discount on SEO Services 2
... it plans to report third quarter 2008 financial results before the market ... ... Wire EON) October 30, 2008 -- The company also plans to ... in New York City on November 3, 2008 at 11:20 a.m. EST ...
... Election Day, researchers from Harvard School of Public Health and ... New England Journal of Medicine, find that seven ... the U.S. health care system. , The article, written by ... Analysis at the Harvard School of Public Health, Drew E. ...
... Inc.,(NYSE: RBN ) announced today that it will ... on November 10th at 11:35 a.m. (Eastern) at The,Peninsula ... Chief,Executive Officer and Christopher M. Hix, Vice President and ... the presentation,will be made available on the Company,s website ...
... BATESVILLE, Ind., Oct. 30 Hill-Rom Holdings,Inc.,s, (NYSE: ... earnings,release will be issued Monday, November 10, 2008. You ... on Tuesday, November 11,2008 at 8 a.m. EST., ... Year End Earnings Release for the quarter and year ...
... DIEGO, Oct. 30 AMN Healthcare Services,Inc. (NYSE: AHS ) ... -- Revenue of $315 million, up 5% over last ... slightly below Company guidance. -- Revenue growth primarily driven by ... largest segments, Nurse & Allied and Locum Tenens. -- EPS ...
... DATA ), a technology and services company focused ... announced that,it will host a conference call to discuss ... 4:30 p.m. ET on Thursday, November 6, 2008., ... 412-858-4600 a,few minutes before 4:30 p.m. ET. The conference ...
Cached Medicine News:Health News: Dynavax to Report Third Quarter 2008 Financial Results : -- To Present at Oppenheimer's Healthcare Conference -- 2Health News:Pre-election surveys show deep concern about state of health care 2Health News:Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Fourth Quarter and Year End Earnings Webcast 2Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 2Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 3Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 4Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 5Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 6Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 7Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 8Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 9Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 10Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 11Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 12Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 13Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 14Health News:AMN Healthcare Announces Third Quarter 2008 Results and Updates Full Year Guidance 15Health News:DATATRAK International Management to Host Conference Call on November 6, 2008 to Discuss Third Quarter and Nine Month Operating Results for 2008 2Health News:DATATRAK International Management to Host Conference Call on November 6, 2008 to Discuss Third Quarter and Nine Month Operating Results for 2008 3
(Date:8/29/2014)... 29, 2014  United Therapeutics Corporation (NASDAQ: ... for the District of New Jersey ... case against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... ruled that U.S. Patent No. 6,765,117 is both valid ... marketing its generic product until the expiration of that ...
(Date:8/29/2014)... -- ChemImage will present a workshop focused on hyperspectral ... Science Society,s 22 nd International Symposium on ... .  Forensic Scientists will be in attendance ... can bring to examination procedures. ... Development at ChemImage, will host a workshop during ...
(Date:8/29/2014)... Columbia and MENLO PARK, Calif. ... DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") ... year-end financial statements.  The Company recently changed its fiscal ... an application to list its common stock on a ... DelMar,s financial statements as filed with the United ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... 8, 2011 K-V Pharmaceutical Company (NYSE: KV.A/ KV.B) (the ... ® , the only U.S. Food & Drug Administration ("FDA") ... in women with singleton pregnancy who have a history of ... was launched during March of 2011. From its launch date ...
... 8, 2011 Thompson MIS is pleased to announce ... "Best New Technology for Spine Care in 2011" award ... the company during the annual meeting of the North ... is a patented system that enables surgeons to more ...
Cached Medicine Technology:K-V Pharmaceutical Announces Updated Makena® Performance Metrics 2K-V Pharmaceutical Announces Updated Makena® Performance Metrics 3K-V Pharmaceutical Announces Updated Makena® Performance Metrics 4K-V Pharmaceutical Announces Updated Makena® Performance Metrics 5K-V Pharmaceutical Announces Updated Makena® Performance Metrics 6K-V Pharmaceutical Announces Updated Makena® Performance Metrics 7K-V Pharmaceutical Announces Updated Makena® Performance Metrics 8
Titanium. Curved shafts with 5.5 mm tying platform. Round knurled handle with dull finish. Overall length 4.3 inches....
Angled 45 degree shafts 8 mm from tip to bend with 5 mm tying platform. Serrated handle with dull finish. Overall length 3.3 inches....
Angled 45 degree shafts 8 mm from tip to bend with 4 mm tying platform. Smooth handle with dull finish. Overall length 3.2 inches....
Straight shafts with 4 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches....
Medicine Products: